European Union drug regulators said they are currently assessing whether to recommend COVID-19 booster shots, according to a statement posted Monday.
The European Medicines Agency (EMA) said it is evaluating individuals over the age of 16 to receive another vaccine six months after the second dose.
“People whose immune system is significantly weakened as part of their primary vaccination should already consider additional vaccinations.” The agency said The statement claims that the vaccine provides protection against hospitalization and death.
Authorities have not stated whether booster doses are effective in preventing COVID-19 infection. A study published last month by the Centers for Disease Control and Prevention (CDC) found that vaccines may not be able to prevent the transmission of the virus.
“It’s important to distinguish between booster doses for people with a normal immune system and additional doses for people with a weakened immune system,” EMA added. “Several studies have reported that additional vaccination can improve the immune response of immunocompromised individuals, such as organ transplant recipients, who had a low initial response to vaccination. Options for administering doses should already be considered. “
And now EU regulators have said they will work to provide boosters to the “elderly” and “weak”, those who live in long-term care facilities and elderly housing with care.
If boosters are deployed in large numbers throughout Europe, encourage criticism from the World Health Organization (WHO), which frequently demands the EU and US to put a moratorium on the development of booster shots in support of the provision of COVID. That’s for sure-19 vaccines for poor countries.
In the United States, federal health officials in August said they were targeting September 20 as the day to deploy boosters to most Americans.
During Sunday’s update, Biden’s COVID-19 adviser Anthony Fauci is likely to have the Food and Drug Administration (FDA) approve boosters made by Pfizer and then Moderna by September 20. Said.
“We wanted both candidates, both products, Moderna and Pfizer to be rolled out by the week of the 20th. Only one of them is expected to come out, but the other. May continue shortly thereafter, “Fauci said in an interview with CBS News on Sunday.
Pfizer has already submitted the data and said it was “likely to meet the deadline.” The Moderna booster may then be approved by the FDA. He does not mention the Johnson & Johnson COVID-19 vaccine, which uses adenovirus rather than mRNA technology.